ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

WGSWW GeneDx Holdings Corporation

0.1724
0.0124 (7.75%)
Jan 02 2025 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 26,538
Bid Price 0.09
Ask Price 0.16
News (2)
Share Name Share Symbol Market Stock Type
GeneDx Holdings Corporation WGSWW NASDAQ Equity Warrant
  Price Change Price Change % Share Price Last Trade
0.0124 7.75% 0.1724 19:00:00
Open Price Low Price High Price Close Price Previous Close
0.17 0.1401 0.1725 0.1724 0.16
Trades Shares Traded VWAP Financial Volume Average Volume
68 26,538  0.1707187  4,531 -
Last Trade Type Quantity Price Currency
15:00:00 990  0.17 USD

GeneDx Holdings Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
4.14M 25.88M - 202.57M -175.77M -6.79 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

News GeneDx

Date Time Source Heading
1/02/202516:14Edgar (US Regulatory)Form 8-K - Current report
1/02/202516:03Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
12/18/202417:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
12/16/202419:41Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
12/11/202418:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
12/09/202419:06Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
12/03/202418:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
12/02/202419:01Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
11/25/202417:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
11/21/202417:14Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
11/19/202419:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
11/19/202419:00Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No WGSWW Message Board. Create One! See More Posts on WGSWW Message Board See More Message Board Posts

WGSWW Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year0.000.000.000.0000.000.00%
3 Years0.000.000.000.0000.000.00%
5 Years0.000.000.000.0000.000.00%

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It also provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. is headquartered in Stamford, Connecticut.

NASDAQ:WGSWW -

What is the current GeneDx Holdings Corporation share price?
The current share price of GeneDx Holdings Corporation is US$ 0.1724
How many GeneDx Holdings Corporation shares are in issue?
GeneDx Holdings Corporation has 25,884,000 shares in issue
What is the market cap of GeneDx Holdings Corporation?
The market capitalisation of GeneDx Holdings Corporation is USD 4.14M
What is the 1 year trading range for GeneDx Holdings Corporation share price?
GeneDx Holdings Corporation has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the PE ratio of GeneDx Holdings Corporation?
The price to earnings ratio of GeneDx Holdings Corporation is -11.7
What is the cash to sales ratio of GeneDx Holdings Corporation?
The cash to sales ratio of GeneDx Holdings Corporation is 10.15
What is the reporting currency for GeneDx Holdings Corporation?
GeneDx Holdings Corporation reports financial results in USD
What is the latest annual turnover for GeneDx Holdings Corporation?
The latest annual turnover of GeneDx Holdings Corporation is USD 202.57M
What is the latest annual profit for GeneDx Holdings Corporation?
The latest annual profit of GeneDx Holdings Corporation is USD -175.77M
What is the registered address of GeneDx Holdings Corporation?
The registered address for GeneDx Holdings Corporation is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the GeneDx Holdings Corporation website address?
The website address for GeneDx Holdings Corporation is www.genedx.com
Which industry sector does GeneDx Holdings Corporation operate in?
GeneDx Holdings Corporation operates in the HEALTH SERVICES sector

Your Recent History

Delayed Upgrade Clock